Preview Mode Links will not work in preview mode

This Week in Cardiology

Aug 27, 2021

COVID-19, NEJM vaccine safety paper, full-dose anticoagulation in COVID-19, AF and Exercise, and early results on EMPEROR-Preserved are the studies John Mandrola, MD, discusses in this week’s podcast.

1 - COVID-19

- Heart Inflammation More Common After COVID Than After Vaccination

- Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

2 - Full dose AC in COVID-19

- Heparin's COVID-19 Benefit Greatest in Moderately Ill Patients

- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

3 - AF and Exercise

- Aerobic Exercise Can Reduce AF Frequency, Severity: ACTIVE-AF


- EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact